- (2023). GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nature Cancer.
- (2022). Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells. Viruses. 25 sider.
- (2021). TGF-β promotes microtube formation in glioblastoma through thrombospondin 1. Neuro-Oncology. 541-553.
- (2021). Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry. Nature Communications.
- (2021). Comparing tumor cell invasion and myeloid cell composition in compatible primary and relapsing glioblastoma. Cancers. 1-17.
- (2020). Letter regarding "Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas". Neuro-Oncology. 1882-1883.
- (2019). Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. Neuro-Oncology. 890-900.
- (2017). The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro-Oncology. 383-393.
- (2016). Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells. Journal of Gene Medicine. 234-243.
- (2016). EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro-Oncology. 1644-1655.
- (2023). Investigation of the apoptotic pathway in glioblastoma in the context of suicide gene therapy.
- (2020). Studies on the Molecular Mechanisms of the Bystander Effect in HSV-TK mediated Suicide Gene Therapy for Glioblastoma Treatment.
- (2019). Use of Gap Junction Enhanching Drugs to Increase the Bystander Effect of Sucide Gene Therapy for Glioblastoma Treatment.
- (2017). Screening of tumor suppressor microRNAs to boost the killing efficacy of suicide gene therapy for brain cancer treatment.
- (2019). Cancer Suicide Gene Therapy with TK.007. 16 sider.
- (2022). Tumor-associated macrophages in gliomas—basic insights and treatment opportunities. Cancers. 1-25.
- (2020). Suicide gene therapy for the treatment of high-grade glioma: Past lessons, present trends, and future prospects. Neuro-Oncology Advances (NOA).